Does anyone know if this company is still operating?, page-26

It is difficult to predict short-term trends, but for a six-month cycle, I believe the final $25M will be the last support OIC can provide. It is challenging for CBR to secure funding continuously, unlike some pharmaceutical companies. Therefore, in the first half of 2026, CBR will either have to achieve profitability or push up the share price to execute a capital raise.
Based on the latest updates, by the end of 2023, CBR's total production was close to 80,000 units. The most recent information indicates their total production has just exceeded 100,000 units, meaning they only produced about 20,000 wheels in 2024, which is far below the breakeven point of 45,000–50,000 units annually.This makes it a certainty that CBR will not achieve profitability in the first half of 2026. As a result, they must either push up the share price to execute a CR or face delisting.